Search - tctmd.com

Displaying 381 - 400 of 465

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Presenter: Ashish Pershad, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Presenter: Anthony N. DeMaria, Allan Schwartz, Scott Lim

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Lessons Learned From Surgery for Functional MR and TR to Guide Transcatheter Therapies

Presenter: Anthony N. DeMaria, Allan Schwartz, David H. Adams

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Shelley Wood

June 18, 2018

Podcast TCTMD Talking Points

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

June 06, 2018

Presentation EuroPCR 2018

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Presenter: Lars Sondergaard

May 25, 2018

Presentation EuroPCR 2018

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

Presenter: David Muller

May 25, 2018

Presentation EuroPCR 2018

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

Presenter: Mayra Guerrero

May 24, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

News CV Team Pro

Featured Cath Lab Pro: Marian Hawkey

May 20, 2018

Podcast TCTMD Talking Points

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

May 16, 2018

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

News Industry News

Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use

May 09, 2018

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

News Industry News

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

May 01, 2018

Presentation SCAI 2018

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement

Presenter: Sahil Khera

April 28, 2018

Advertisement

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Lessons Learned From Surgery for Functional MR and TR to Guide Transcatheter Therapies

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Featured Cath Lab Pro: Marian Hawkey

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content